01 1DARMERICA, LLC
02 1KALINTIS HEALTHCARE PRIVATE LIMITED
03 1LETCO MEDICAL, LLC
04 1MEDISCA Inc.
05 1Olon SpA
06 1Professional Compounding Centers of America
07 1Professional Compounding Centers of America dba PCCA
08 1Spectrum Laboratory Products, Inc.
09 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
10 1Zhejiang Supor Pharmaceuticals Co., Ltd
01 2KETOTIFEN FUMARATE
02 7Ketotifen Fumarate
03 1Ketotifen Hydrogen Fumarate
01 2China
02 1India
03 1Italy
04 4U.S.A
05 2United Kingdom
NDC Package Code : 71052-377
Start Marketing Date : 2020-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25g/25g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72166-021
Start Marketing Date : 2024-08-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2967
Start Marketing Date : 2010-11-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2973
Start Marketing Date : 2019-06-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0522
Start Marketing Date : 2017-01-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0014
Start Marketing Date : 2015-10-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0148
Start Marketing Date : 2020-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3923
Start Marketing Date : 2009-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-146
Start Marketing Date : 2024-06-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14799-2021
Start Marketing Date : 2012-10-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ketotifen Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketotifen Fumarate, including repackagers and relabelers. The FDA regulates Ketotifen Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketotifen Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ketotifen Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ketotifen Fumarate supplier is an individual or a company that provides Ketotifen Fumarate active pharmaceutical ingredient (API) or Ketotifen Fumarate finished formulations upon request. The Ketotifen Fumarate suppliers may include Ketotifen Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Ketotifen Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ketotifen Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ketotifen Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ketotifen Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ketotifen Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ketotifen Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ketotifen Fumarate suppliers with NDC on PharmaCompass.
We have 9 companies offering Ketotifen Fumarate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
